Passion for Veterinary Innovations
Français 
Home
Research & development
Quality
Products
News
Business development
Contact
Careers
News
 

Miami, FL January 6, 2016 — Modern Veterinary Therapeutics, LLC announces that the Veterinary Drugs Directorate (VDD) has approved Nerfasin 100TM (xylazine injection - 100mg/mL) in Canada. Nerfasin 100TM, presented in a 50mL vial, is indicated for use in horses when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia. "Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada which further expands our veterinary line of sedative and analgesic products," said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.

 

modern_veterinary_therapeutics_0914024001.jpg